DF
NVO

Dunhill Financial’s Novo Nordisk NVO Stock Holding History

Dunhill Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.6K Buy
1,972
+1,432
+265% +$61.5K 0.02% 231
2026
Q1 		$19.8K Hold
540
– – ﹤0.01% 431
2025
Q4 		$27.5K Sell
540
-532
-50% -$27.2K 0.01% 349
2025
Q3 		$59.5K Sell
1,072
-298
-22% -$17.4K 0.02% 236
2025
Q2 		$94.6K Buy
1,370
+463
+51% +$31.5K 0.03% 171
2025
Q1 		$63K Sell
907
-134
-13% -$11.1K 0.03% 172
2024
Q4 		$89.5K Buy
1,041
+572
+122% +$61.9K 0.04% 137
2024
Q3 		$55.8K Buy
469
+311
+197% +$41.5K 0.03% 163
2024
Q2 		$22.6K Hold
158
– – 0.01% 200
2024
Q1 		$20.3K Buy
158
+20
+14% +$2.38K 0.02% 173
2023
Q4 		$12.9K Buy
+138
New +$13.6K 0.01% 176

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Dunhill Financial's NVO Position: Q2 2026 in Review

Dunhill Financial increased its Novo Nordisk (NVO) stake by 265% in Q2 2026, buying an estimated $61.5K and bringing the position to 1,972 shares worth $94.6K. The position accounts for 0.02% of the portfolio, ranked #231.

Dunhill Financial first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $94.6K in Q2 2025. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Dunhill Financial held 1,972 shares of Novo Nordisk worth $94.6K as of Q2 2026.
  • Dunhill Financial bought 1,432 Novo Nordisk shares in Q2 2026, an estimated $61.5K.
  • Novo Nordisk made up 0.02% of Dunhill Financial's portfolio in Q2 2026, its #231 holding.
  • Dunhill Financial first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Novo Nordisk position peaked at $94.6K in Q2 2025.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.